These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Developments in large and midsize vasculitis. Terreri MT; Clemente G Rheum Dis Clin North Am; 2013 Nov; 39(4):855-75. PubMed ID: 24182858 [TBL] [Abstract][Full Text] [Related]
7. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications. De Rosa G; Pardeo M; Rigante D Eur Rev Med Pharmacol Sci; 2007; 11(5):301-8. PubMed ID: 18074939 [TBL] [Abstract][Full Text] [Related]
14. Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey. Ozdemir H; Ciftçi E; Tapisiz A; Ince E; Tutar E; Atalay S; Dogru U J Trop Pediatr; 2010 Aug; 56(4):260-2. PubMed ID: 20007257 [TBL] [Abstract][Full Text] [Related]
15. Kawasaki disease: part II. Complications and treatment. Bayers S; Shulman ST; Paller AS J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380 [TBL] [Abstract][Full Text] [Related]
16. The diagnosis and management of Kawasaki disease. Royle J; Burgner D; Curtis N J Paediatr Child Health; 2005 Mar; 41(3):87-93. PubMed ID: 15790316 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of Kawasaki disease in infants younger than six months of age. Chang FY; Hwang B; Chen SJ; Lee PC; Meng CC; Lu JH Pediatr Infect Dis J; 2006 Mar; 25(3):241-4. PubMed ID: 16511387 [TBL] [Abstract][Full Text] [Related]
18. [Kawasaki disease: what you need to know]. Bajolle F; Laux D Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712 [TBL] [Abstract][Full Text] [Related]